Literature DB >> 30173005

Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art.

Morgan Pantuck1, Nicolaos Palaskas2, Alexandra Drakaki3.   

Abstract

Entities:  

Keywords:  Bladder cancer; CAR; Genitourinary; Immunotherapy; Kidney cancer; Prostate cancer; T-cell; TCR

Mesh：

Substances：

Year:  2018        PMID： 30173005     DOI： 10.1016/j.ctarc.2018.08.001

Source DB:  PubMed          Journal:  Cancer Treat Res Commun        ISSN： 2468-2942


× No keyword cloud information.
  2 in total

1.  Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro.

Authors:  Lei Yu; Zhichao Li; Hongbin Mei; Wujiao Li; Dong Chen; Lisa Liu; Zhongfu Zhang; Yangyang Sun; Fei Song; Wei Chen; Weiren Huang
Journal:  Clin Transl Immunology       Date:  2021-01-31

Review 2.  Cell Therapies in Bladder Cancer Management.

Authors:  Lucia Morales; Jesús M Paramio
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.